ASKA Pharmaceutical Co., Ltd. Stock Japan Exchange
Equities
4514
JP3541200006
Pharmaceuticals
Sales 2024 * | 63.28B 409M | Sales 2025 * | 64.65B 418M | Capitalization | 62.52B 404M |
---|---|---|---|---|---|
Net income 2024 * | 6.47B 41.8M | Net income 2025 * | 4.89B 31.63M | EV / Sales 2024 * | 0.73 x |
Net cash position 2024 * | 16.35B 106M | Net cash position 2025 * | 20.83B 135M | EV / Sales 2025 * | 0.64 x |
P/E ratio 2024 * |
9.66
x | P/E ratio 2025 * |
12.8
x | Employees | 747 |
Yield 2024 * |
1.81% | Yield 2025 * |
2.17% | Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
President | 71 | 21-03-31 | |
Kiyohiko Tamura
ADM | Chief Administrative Officer | - | - |
Kunihiro Gunji
CMP | Compliance Officer | - | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
President | 71 | 21-03-31 | |
Atsushi Maruo
BRD | Director/Board Member | 65 | 21-03-31 |
Director/Board Member | 75 | 21-03-31 |
1st Jan change | Capi. | |
---|---|---|
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B |